Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
3.350
-0.190 (-5.37%)
At close: Sep 1, 2026, 4:00 PM EDT
3.280
-0.070 (-2.09%)
Pre-market: Sep 2, 2026, 6:18 AM EDT
Jupiter Neurosciences Revenue
Jupiter Neurosciences had revenue of $24.25K in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $64.69K. In the year 2025, Jupiter Neurosciences had annual revenue of $21.80K.
Revenue (ttm)
$64.69K
Revenue Growth
n/a
P/S Ratio
39.88
Revenue / Employee
$12,939
Employees
5
Market Cap
2.58M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21.80K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 233.28K | -404.76K | -63.44% |
| Dec 31, 2021 | 638.04K | -488.20K | -43.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BioAtla | 8.50M |
| Curis | 4.31M |
| Onconetix | 645.82K |
| Decoy Therapeutics | 227.63K |
| Endovia Health Sciences | 32.09K |
| Virax Biolabs Group | 12.42K |
JUNS News
- 11 days ago - Why Is Penny Stock Jupiter Neurosciences (JUNS) Up Today? - TipRanks
- 11 days ago - Jupiter Neurosciences announces pricing of $2M registered direct offering - TheFly
- 11 days ago - Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering - GlobeNewsWire
- 11 days ago - Jupiter Neurosciences Inc trading resumes - TheFly
- 11 days ago - Jupiter Neurosciences Inc trading halted, volatility trading pause - TheFly
- 26 days ago - Jupiter Neurosciences Inc trading halted, news pending - TheFly
- 27 days ago - Jupiter Neurosciences announces 1-for-75 reverse stock split - TheFly
- 27 days ago - Jupiter Neurosciences, Inc. Announces Reverse Stock Split - GlobeNewsWire